Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/130-tenere-a-multi-center-randomized-parallel-group-rater-blinded-study-comparing-the-effectiveness-and-safety-of-teriflunomide-and-interferon-beta-1a-in-patients-with-relapsing-multiple-sclerosis/publications